TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29277560

Group type: EXPERIMENTAL
Intervention: Cx601 (120 million allogeneic expanded adipose-derived stem cells)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 212
Study: 26927298

Group type: EXPERIMENTAL
Intervention: Routine coronary angiography without a previous non-invasive stress test before PTA
Number of subjects: 450

Group type: COMPARATOR
Intervention: Selective coronary angiography based on the results of non-invasive stress tests before PTA
Number of subjects: 450
Study: 24858657

Group type: EXPERIMENTAL
Intervention: Beetroot juice (nitrate content 7.5 mmol per 250 ml)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (nitrate depleted beetroot juice, nitrate content 0.002 mmol per 250 ml)
Number of subjects: 27
Study: 22344613

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 40
Study: 19056592

Group type: EXPERIMENTAL
Intervention: 20 mg liquid DHA
Number of subjects: 1160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1160
Study: 17806025

Group type: EXPERIMENTAL
Intervention: Post‐incisional wound infiltration with levobupivacaine 1.25 mg/kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Paracetamol 30 mg/kg administered rectally
Number of subjects: 30
Study: 12969370

Group type: EXPERIMENTAL
Intervention: Bioabsorbable polylactide-polyglycolide acid sponge (Fisiograft)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Natural healing by clot formation (Control)
Number of subjects: 36
Study: 11094004

Group type: EXPERIMENTAL
Intervention: Ketamine (25 mg/24 h)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 8720405

Group type: EXPERIMENTAL
Intervention: Longitudinal durotomy during laminoplasty
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (no longitudinal durotomy)
Number of subjects: 118
Study: 1357349

Group type: EXPERIMENTAL
Intervention: Doppler velocimetry
Number of subjects: 426

Group type: COMPARATOR
Intervention: CTG
Number of subjects: 426
Study: 4004602

Group type: EXPERIMENTAL
Intervention: Naproxen sodium
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 31450957

Group type: EXPERIMENTAL
Intervention: Bayesian trials (283 trials)
Number of subjects: 1020

Group type: EXPERIMENTAL
Intervention: Bayesian trials
Number of subjects: 1020

Group type: EXPERIMENTAL
Intervention: Bayesian methods for trial design and primary endpoint analysis (75 trials)
Number of subjects: 1020

Group type: EXPERIMENTAL
Intervention: BATTLE trial
Number of subjects: 1020

Group type: EXPERIMENTAL
Intervention: I-SPY 2 trial
Number of subjects: 1020
Study: 27660289

Group type: EXPERIMENTAL
Intervention: Whey protein treatment
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Zinc, selenium, glutamine, and metoclopramide treatment
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Both nutraceutical strategies
Number of subjects: 240
Study: 25567765

Group type: EXPERIMENTAL
Intervention: Bone marrow mononuclear cells (BMMNCs)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 22893099

Group type: EXPERIMENTAL
Intervention: Manual cell identification on Robo and Confoscan 4 images
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Confoscan automated cell detection software
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Robo automated cell detection software
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: EM‐3000 automated cell detection
Number of subjects: 82
Study: 21403038

Group type: EXPERIMENTAL
Intervention: Intensive diabetes therapy
Number of subjects: 325
Study: 19135567

Group type: EXPERIMENTAL
Intervention: 20 mcg of EE and 150 mcg of desogestrel (DSG) for 6 months
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 30 mcg of EE and 2 mg of chlormadinone acetate (CMA) for 6 months
Number of subjects: 28

Group type: COMPARATOR
Intervention: Both treatments (EE/DSG and EE/CMA)
Number of subjects: 28
Study: 17386385

Group type: EXPERIMENTAL
Intervention: Injection of technetium 99m sestamibi at 30 to 60 minutes after balloon inflation (group 1, n = 20)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Injection of technetium 99m sestamibi at 90 to 120 minutes after balloon inflation (group 2, n = 10)
Number of subjects: 30
Study: 14734128

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 2 g/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 30
Study: 11726454

Group type: EXPERIMENTAL
Intervention: IV midazolam
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fentanyl plus midazolam
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: No sedative
Number of subjects: 60

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 60
Study: 8989332

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (single intramuscular dose, maximum dose of 50 mg/kg)
Number of subjects: 484

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (10 days of oral treatment, 8 mg of TMP and 40 mg of SMZ/kg/day in two divided doses)
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 484

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 484
Study: 8516652

Group type: EXPERIMENTAL
Intervention: 10 mg cisapride
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3731687

Group type: EXPERIMENTAL
Intervention: verapamil
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: diltiazem
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: nifedipine
Number of subjects: 10
Study: 31820836

Group type: EXPERIMENTAL
Intervention: Web-based education (educational videos about cervical cancer and Pap smear test)
Number of subjects: 1290

Group type: COMPARATOR
Intervention: Control group (no web-based education)
Number of subjects: 1290

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1290

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 1290
Study: 31326117

Group type: EXPERIMENTAL
Intervention: Peek Acuity
Number of subjects: 111
Study: 27749358

Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR) training
Number of subjects: 17
Study: 23849005

Group type: EXPERIMENTAL
Intervention: Community pharmacist's intervention (drug dosing adjustment service)
Number of subjects: 40
Study: 22004351

Group type: EXPERIMENTAL
Intervention: Early Head Start (EHS) program
Number of subjects: 3001
Study: 19380288

Group type: EXPERIMENTAL
Intervention: Hyaluronan
Number of subjects: 60

Group type: COMPARATOR
Intervention: Triamcinolone
Number of subjects: 60
Study: 16670361

Group type: EXPERIMENTAL
Intervention: 5‐HT3 receptor antagonist (5‐HT3RA) plus dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5‐HT3 receptor antagonist (5‐HT3RA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 0
Study: 15248875

Group type: EXPERIMENTAL
Intervention: Astra Tech implants
Number of subjects: 66

Group type: COMPARATOR
Intervention: Brånemark implants
Number of subjects: 66
Study: 11422089

Group type: EXPERIMENTAL
Intervention: Intravenous metamizol
Number of subjects: 179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study: 10437252

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) drugs for supporting healthy energy and removing blood stasis
Number of subjects: 32

Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 32
Study: 7873465

Group type: EXPERIMENTAL
Intervention: Enalapril (ACE inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional therapeutic regimens
Number of subjects: 0
Study: 3061846

Group type: EXPERIMENTAL
Intervention: Lymecycline therapy (300 mg b.i.d. for 14 days)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Lymecycline therapy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Lymecycline therapy and Placebo
Number of subjects: 55
Study: 29884735

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia
Number of subjects: 181

Group type: COMPARATOR
Intervention: Therapeutic normothermia
Number of subjects: 181
Study: 27050187

Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 797

Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 797
Study: 25155103

Group type: EXPERIMENTAL
Intervention: CDS assistance
Number of subjects: 30

Group type: COMPARATOR
Intervention: No CDS assistance
Number of subjects: 30
Study: 21801330

Group type: EXPERIMENTAL
Intervention: Bovine colostrum
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 21262893

Group type: EXPERIMENTAL
Intervention: Pregnancy screener
Number of subjects: 4889

Group type: EXPERIMENTAL
Intervention: Enumeration and pregnancy screening
Number of subjects: 4889

Group type: EXPERIMENTAL
Intervention: Consent process
Number of subjects: 4889

Group type: EXPERIMENTAL
Intervention: Community-level variables
Number of subjects: 4889
Study: 18163999

Group type: EXPERIMENTAL
Intervention: Coasting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cryopreservation of all embryos
Number of subjects: 0
Study: 16526560

Group type: EXPERIMENTAL
Intervention: 75 mg TLP (Talampanel) administered orally in fasted and fed states.
Number of subjects: 28
Study: 12517808

Group type: EXPERIMENTAL
Intervention: Prednisone (60 mg/m2)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Dexamethasone (10 mg/m2)
Number of subjects: 336
Study: 10644869

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccination after one dose of GM-CSF (24 hours post-administration)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Booster dose of hepatitis B vaccine after one dose of GM-CSF (24 hours post-administration)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Hepatitis B vaccination alone (control for primary immunization)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Booster dose of hepatitis B vaccine alone (control for booster dose)
Number of subjects: 28
Study: 8795443

Group type: EXPERIMENTAL
Intervention: Finger arterial pressure (FINAP)
Number of subjects: 8
Study: 2252161

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (IT) with an alginate-conjugated extract of D. pteronyssinus
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 33
Study: 6794308

Group type: EXPERIMENTAL
Intervention: Soluble aspirin daily for 6 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no aspirin)
Number of subjects: 100
Study: 30359862

Group type: EXPERIMENTAL
Intervention: Nonfat dairy milk (NFM)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Full-fat dairy milk (FFM)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Glucose (GLU)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Nonfat dairy milk (NFM) and Full-fat dairy milk (FFM)
Number of subjects: 22
Study: 28401794

Group type: EXPERIMENTAL
Intervention: Low-dose radioiodine (1850 MBq)
Number of subjects: 278

Group type: COMPARATOR
Intervention: High-dose radioiodine (3700 MBq)
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 278
Study: 24360978

Group type: EXPERIMENTAL
Intervention: High-dose soy isoflavone (300 mg/day)
Number of subjects: 431

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 431
Study: 23786894

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 5mg
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10mg
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 20mg
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: ASA plus Rivaroxaban 5mg
Number of subjects: 51

Group type: COMPARATOR
Intervention: ASA plus Clopidogrel
Number of subjects: 51

Group type: COMPARATOR
Intervention: ASA alone
Number of subjects: 51
Study: 21794791

Group type: EXPERIMENTAL
Intervention: Laser intervention with girlase E11010, applied individually with six frequencies on seven anatomical zones
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 19366845

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training for 16 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (healthy BMI-matched women)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic euglycemic clamp
Number of subjects: 15
Study: 17131283

Group type: EXPERIMENTAL
Intervention: Demographic and clinical variables assessed early during hospitalization
Number of subjects: 163
Study: 15295364

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 921
Study: 11089822

Group type: EXPERIMENTAL
Intervention: Stiripentol
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 9573762

Group type: EXPERIMENTAL
Intervention: Colchicine (1 mg daily for 5 days a week)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 7893931

Group type: EXPERIMENTAL
Intervention: Elastic compression of an upper limb
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Elastic compression of the lower limbs
Number of subjects: 21

Group type: COMPARATOR
Intervention: Without elastic compression
Number of subjects: 21
Study: 3141887

Group type: EXPERIMENTAL
Intervention: 1 g ceftriaxone
Number of subjects: 52

Group type: COMPARATOR
Intervention: 2 g ceftriaxone
Number of subjects: 52
Study: 29464504

Group type: EXPERIMENTAL
Intervention: 2 mg/kg/h of propofol (P2)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 1 mg/kg/h of propofol (P1)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg/h of propofol (P0.5)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: All groups (P2, P1, P0.5)
Number of subjects: 66
Study: 28762140

Group type: EXPERIMENTAL
Intervention: Cap-assisted sigmoidoscopy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-cap-assisted sigmoidoscopy
Number of subjects: 0
Study: 24424711

Group type: EXPERIMENTAL
Intervention: 90 mg rimonabant
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 22754096

Group type: EXPERIMENTAL
Intervention: succinylcholine (1.0 mg/kg BW)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: rocuronium (0.5 mg/kg BW)
Number of subjects: 27

Group type: COMPARATOR
Intervention: saline (15 mL)
Number of subjects: 27
Study: 19924124

Group type: EXPERIMENTAL
Intervention: St John's wort (300 mg t.i.d.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ritonavir (300 mg b.i.d.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Coadministration of St John's wort and ritonavir
Number of subjects: 12
Study: 18515308

Group type: EXPERIMENTAL
Intervention: Intravenous calcitriol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Daily orally administered calcitriol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (oral and intravenous calcitriol)
Number of subjects: 60
Study: 15871845

Group type: EXPERIMENTAL
Intervention: Nateglinide (120 mg)
Number of subjects: 10
Study: 12678355

Group type: EXPERIMENTAL
Intervention: Single deep closed-suction drain
Number of subjects: 100

Group type: COMPARATOR
Intervention: No drain
Number of subjects: 100
Study: 10783996

Group type: EXPERIMENTAL
Intervention: 20 mg pantoprazole
Number of subjects: 433

Group type: COMPARATOR
Intervention: 40 mg pantoprazole
Number of subjects: 433
Study: 8843129

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo tablets (first half of therapy)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Antioxidant supplements (second half of therapy)
Number of subjects: 8
Study: 1609035

Group type: EXPERIMENTAL
Intervention: Buprenorphine (1.5-8.0 mg/day)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Dose reductions (10% twice weekly for 5 weeks to zero dose, then placebo for 2 weeks)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Stable dose for 7 weeks
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Discontinuation trial (n = 51)
Number of subjects: 85
Study: 3086061

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg enteric-coated granules, once daily for nine days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30220235

Group type: EXPERIMENTAL
Intervention: Nintedanib plus Sildenafil (nintedanib at a dose of 150 mg twice daily plus sildenafil at a dose of 20 mg three times daily)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Nintedanib (nintedanib at a dose of 150 mg twice daily plus placebo three times daily)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Nintedanib plus Sildenafil
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Nintedanib plus Sildenafil and Nintedanib
Number of subjects: 274
Study: 25898895

Group type: EXPERIMENTAL
Intervention: PMMA-based fixed dental prostheses (FDP)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cantilevered FDPs
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Standard design FDPs (n=37)
Number of subjects: 27
Study: 25226602

Group type: EXPERIMENTAL
Intervention: Autonomy-supportive intervention program
Number of subjects: 27

Group type: COMPARATOR
Intervention: Existing teaching style
Number of subjects: 27
Study: 22926446

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Axillary lymph node dissection (ALND)
Number of subjects: 0
Study: 20435656

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 1409
Study: 19126851

Group type: EXPERIMENTAL
Intervention: Concurrent tracking task during stepping trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: No concurrent tracking task during stepping trials
Number of subjects: 0
Study: 17072049

Group type: EXPERIMENTAL
Intervention: Physical exercise (Bruce protocol exercise test)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Healthy controls (no exercise)
Number of subjects: 44
Study: 12967799

Group type: EXPERIMENTAL
Intervention: Trabeculectomy
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Ahmed glaucoma valve implant
Number of subjects: 123

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 123
Study: 10898322

Group type: EXPERIMENTAL
Intervention: Famciclovir 500 mg three times daily (tid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Famciclovir 125 mg, 250 mg, 500 mg three times daily (tid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9273203

Group type: EXPERIMENTAL
Intervention: 1% histamine solution
Number of subjects: 71
Study: 1735846

Group type: EXPERIMENTAL
Intervention: Exogenous synthetic surfactant (Exosurf Neonatal)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Air placebo
Number of subjects: 32
Study: 6877956

Group type: EXPERIMENTAL
Intervention: specific scanning strategies
Number of subjects: 52

Group type: COMPARATOR
Intervention: word-matching exercises
Number of subjects: 52
Study: 31433304

Group type: EXPERIMENTAL
Intervention: DOR 100 mg + TDF 300 mg (Study 1)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: DOR 100 mg + 3TC 300 mg + TDF 300 mg (Study 2)
Number of subjects: 23

Group type: COMPARATOR
Intervention: 3TC 300 mg + TDF 300 mg (Study 2)
Number of subjects: 23
Study: 29110567

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg plaster
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo plaster
Number of subjects: 130
Study: 27029350

Group type: EXPERIMENTAL
Intervention: Catheter ablation (CA) for AF
Number of subjects: 203

Group type: COMPARATOR
Intervention: Amiodarone (AMIO)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Catheter ablation (CA)
Number of subjects: 203
Study: 24594678

Group type: EXPERIMENTAL
Intervention: 200 μg of LSD
Number of subjects: 12

Group type: COMPARATOR
Intervention: 20 μg of LSD (with crossover to 200 μg after unmasking)
Number of subjects: 12
Study: 22138521

Group type: EXPERIMENTAL
Intervention: Adjuvant multiple micronutrient (MMN) supplementation
Number of subjects: 58

Group type: COMPARATOR
Intervention: Folic acid
Number of subjects: 58
Study: 19562652

Group type: EXPERIMENTAL
Intervention: Cranberry (C) two times daily (C, C; n = 10 pregnant)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cranberry in the AM, then placebo (P) in the PM (C, P; n = 9 pregnant)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo two times daily (P, P; n = 8 pregnant)
Number of subjects: 27
Study: 19102746

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine tablets (Coartem)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Artemether-lumefantrine suspension (Co-artesiane)
Number of subjects: 245
Study: 15480571

Group type: EXPERIMENTAL
Intervention: Strontium ranelate (2 g daily)
Number of subjects: 0
Study: 11903272

Group type: EXPERIMENTAL
Intervention: Educational and systems strategies targeting rural primary-care physicians
Number of subjects: 2093
Study: 9932992

Group type: EXPERIMENTAL
Intervention: Photorefractive keratectomy
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Laser in situ keratomileusis
Number of subjects: 22
Study: 7598056

Group type: EXPERIMENTAL
Intervention: 30 g alcohol/d for three menstrual cycles
Number of subjects: 18

Group type: COMPARATOR
Intervention: Alcohol intake phase
Number of subjects: 18
Study: 2115613

Group type: EXPERIMENTAL
Intervention: Higher dose (HD) of 0.1 mg/sqm, three times a week
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lower dose (LD) of 0.01 mg/sqm, three times a week
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Human recombinant gamma‐interferon (r‐IFN‐gamma) therapy
Number of subjects: 30
Study: 31060615

Group type: EXPERIMENTAL
Intervention: 60 mg elemental iron and 2.8 mg folic acid
Number of subjects: 1959

Group type: COMPARATOR
Intervention: Folic acid alone
Number of subjects: 1959
Study: 28586713

Group type: EXPERIMENTAL
Intervention: Guided Internet-Based Cognitive Behavior Therapy (ICBT) for 8 weeks
Number of subjects: 156

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 156
Study: 26125951

Group type: EXPERIMENTAL
Intervention: Tier 2 narrative language intervention, small-group (4:1), 15-20 min, twice a week, for 9 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 22
Study: 23463854

Group type: EXPERIMENTAL
Intervention: Ho'ouna Pono substance use prevention curriculum
Number of subjects: 0
Study: 21514214

Group type: EXPERIMENTAL
Intervention: EEG spectral analysis during motor imagery tasks in patients with severe brain injury (MCS and LIS)
Number of subjects: 3

Group type: COMPARATOR
Intervention: EEG spectral analysis in healthy controls
Number of subjects: 3